UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 234

Sortiert nach

A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis

Blood, 2014-10, Vol.124 (17), p.2687-2697

2014

Volltextzugriff (PDF)

Bim Upregulation by Histone Deacetylase Inhibitors Mediates Interactions with the Bcl-2 Antagonist ABT-737: Evidence for Distinct Roles for Bcl-2, Bcl-xL, and Mcl-1

Molecular and Cellular Biology, 2009-12, Vol.29 (23), p.6149-6169

2009

Volltextzugriff (PDF)

Synergistic Induction of Oxidative Injury and Apoptosis in Human Multiple Myeloma Cells by the Proteasome Inhibitor Bortezomib and Histone Deacetylase Inhibitors

Clinical cancer research, 2004-06, Vol.10 (11), p.3839-3852

2004

Volltextzugriff (PDF)

Targeting SQSTM1/p62 Induces Cargo Loading Failure and Converts Autophagy to Apoptosis via NBK/Bik

Molecular and cellular biology, 2014-09, Vol.34 (18), p.3435-3449

2014

Volltextzugriff (PDF)

Circumvention of Mcl-1-dependent drug resistance by simultaneous Chk1 and MEK1/2 inhibition in human multiple myeloma cells

PloS one, 2014-03, Vol.9 (3), p.e89064

2014

Volltextzugriff (PDF)

The NF (Nuclear factor)‐κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1‐dependent apoptosis in human acute myeloid leukaemia cells

British journal of haematology, 2010-10, Vol.151 (1), p.70-83

2010

Volltextzugriff (PDF)

Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF‐κB and Bim

British journal of haematology, 2011-04, Vol.153 (2), p.222-235

2011

Volltextzugriff (PDF)

Systematic Identification of Bioactive Compositions in Leaves of Morus Cultivars Using UHPLC-ESI-QTOF-MS/MS and Comprehensive Screening of High-Quality Resources

Separations, 2022-03, Vol.9 (3), p.76

2022

Volltextzugriff (PDF)

Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor–induced DNA damage in vitro and in vivo in human multiple myeloma cells

Blood, 2008-09, Vol.112 (6), p.2439-2449

2008

Volltextzugriff (PDF)

CDK Inhibitors Upregulate BH3-Only Proteins to Sensitize Human Myeloma Cells to BH3 Mimetic Therapies

Cancer research (Chicago, Ill.), 2012-08, Vol.72 (16), p.4225-4237

2012

Volltextzugriff (PDF)

Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2

Blood, 2011-11, Vol.118 (19), p.5189-5200

2011

Volltextzugriff (PDF)

Variations in the Levels of Mulberroside A, Oxyresveratrol, and Resveratrol in Mulberries in Different Seasons and during Growth

TheScientificWorld, 2013-01, Vol.2013 (1), p.380692-380692

2013

Volltextzugriff (PDF)

Effect of dissolved oxygen concentration on coke deposition of kerosene

Fuel processing technology, 2016-02, Vol.142, p.86-91

2016

Volltextzugriff (PDF)

Nonlinear response surface in the study of interaction analysis of three combination drugs

Biometrical journal, 2017-01, Vol.59 (1), p.9-24

2017

Volltextzugriff (PDF)

The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical–dependent and Jun NH2-terminal kinase–dependent mechanism

Molecular cancer therapeutics, 2004-12, Vol.3 (12), p.1513-1524

2004

Volltextzugriff (PDF)

MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism

Blood, 2007-09, Vol.110 (6), p.2092-2101

2007

Volltextzugriff (PDF)

The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair

Molecular cancer therapeutics, 2013-06, Vol.12 (6), p.878-889

2013

Volltextzugriff (PDF)

Experimental design and statistical analysis for three-drug combination studies

Statistical methods in medical research, 2017-06, Vol.26 (3), p.1261-1280

2017

Volltextzugriff (PDF)

Subcellular distribution and chemical forms of cadmium in Morus alba L

International journal of phytoremediation, 2018-04, Vol.20 (5), p.448-453

2018

Volltextzugriff (PDF)

Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivo

Molecular cancer therapeutics, 2008-03, Vol.7 (3), p.616-629

2008

Volltextzugriff (PDF)

Disruption of IκB Kinase (IKK)-mediated RelA Serine 536 Phosphorylation Sensitizes Human Multiple Myeloma Cells to Histone Deacetylase (HDAC) Inhibitors

The Journal of biological chemistry, 2011-09, Vol.286 (39), p.34036-34050

2011

Volltextzugriff (PDF)

Dissecting the Roles of Checkpoint Kinase 1/CDC2 and Mitogen-Activated Protein Kinase Kinase 1/2/Extracellular Signal-Regulated Kinase 1/2 in Relation to 7-Hydroxystaurosporine-Induced Apoptosis in Human Multiple Myeloma Cells

Molecular pharmacology, 2006-12, Vol.70 (6), p.1965-1973

2006

Volltextzugriff (PDF)

The Farnesyltransferase Inhibitor L744832 Potentiates UCN-01–Induced Apoptosis in Human Multiple Myeloma Cells

Clinical cancer research, 2005-06, Vol.11 (12), p.4589-4600

2005

Volltextzugriff (PDF)

Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation

Blood, 2007-05, Vol.109 (10), p.4415-4423

2007

Volltextzugriff (PDF)

Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms

Blood, 2004-07, Vol.104 (2), p.509-518

2004

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(201)
Mit Volltextzugriff
(217)

Publikationsform

Sprache

Englisch
(203)
Chinesisch
(33)
Japanisch
(26)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(135)
Life Sciences & Biomedicine
(91)
Humans
(56)
Physical Sciences
(40)
Animals
(36)
Chemistry
(31)
Male
(26)
Biological And Medical Sciences
(21)
Cell Line, Tumor
(20)
Medical Sciences
(19)
Apoptosis - Drug Effects
(18)
Female
(15)
Mice
(15)
Technology
(15)
Rats
(14)
Drug Synergism
(13)
Hematologic And Hematopoietic Diseases
(13)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(13)
Chemistry, Multidisciplinary
(12)
Pharmacology & Pharmacy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis

Bim Upregulation by Histone Deacetylase Inhibitors Mediates Interactions with the Bcl-2 Antagonist ABT-737: Evidence for Distinct Roles for Bcl-2, Bcl-xL, and Mcl-1

Synergistic Induction of Oxidative Injury and Apoptosis in Human Multiple Myeloma Cells by the Proteasome Inhibitor Bortezomib and Histone Deacetylase Inhibitors

Targeting SQSTM1/p62 Induces Cargo Loading Failure and Converts Autophagy to Apoptosis via NBK/Bik

Circumvention of Mcl-1-dependent drug resistance by simultaneous Chk1 and MEK1/2 inhibition in human multiple myeloma cells

The NF (Nuclear factor)‐κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1‐dependent apoptosis in human acute myeloid leukaemia cells

Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF‐κB and Bim

Systematic Identification of Bioactive Compositions in Leaves of Morus Cultivars Using UHPLC-ESI-QTOF-MS/MS and Comprehensive Screening of High-Quality Resources

Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor–induced DNA damage in vitro and in vivo in human multiple myeloma cells

CDK Inhibitors Upregulate BH3-Only Proteins to Sensitize Human Myeloma Cells to BH3 Mimetic Therapies

Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2

Variations in the Levels of Mulberroside A, Oxyresveratrol, and Resveratrol in Mulberries in Different Seasons and during Growth

Effect of dissolved oxygen concentration on coke deposition of kerosene

Nonlinear response surface in the study of interaction analysis of three combination drugs

The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical–dependent and Jun NH2-terminal kinase–dependent mechanism

MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism

The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair

Experimental design and statistical analysis for three-drug combination studies

Subcellular distribution and chemical forms of cadmium in Morus alba L

Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivo

Disruption of IκB Kinase (IKK)-mediated RelA Serine 536 Phosphorylation Sensitizes Human Multiple Myeloma Cells to Histone Deacetylase (HDAC) Inhibitors

Dissecting the Roles of Checkpoint Kinase 1/CDC2 and Mitogen-Activated Protein Kinase Kinase 1/2/Extracellular Signal-Regulated Kinase 1/2 in Relation to 7-Hydroxystaurosporine-Induced Apoptosis in Human Multiple Myeloma Cells

The Farnesyltransferase Inhibitor L744832 Potentiates UCN-01–Induced Apoptosis in Human Multiple Myeloma Cells

Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation

Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms

Suchergebnisse filtern